These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23144046)

  • 21. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of blood glucose concentrations on admission in non-diabetic versus diabetic patients with first acute myocardial infarction on short- and long-term mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry).
    Beck JA; Meisinger C; Heier M; Kuch B; Hörmann A; Greschik C; Koenig W
    Am J Cardiol; 2009 Dec; 104(12):1607-12. PubMed ID: 19962462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.
    Janszky I; Hallqvist J; Tomson T; Ahlbom A; Mukamal KJ; Ahnve S
    Brain; 2009 Oct; 132(Pt 10):2798-804. PubMed ID: 19717532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
    Kosiborod M; Inzucchi SE; Krumholz HM; Xiao L; Jones PG; Fiske S; Masoudi FA; Marso SP; Spertus JA
    Circulation; 2008 Feb; 117(8):1018-27. PubMed ID: 18268145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study.
    Janszky I; Hallqvist J; Ljung R; Ahlbom A; Hammar N
    J Intern Med; 2009 Apr; 265(4):465-75. PubMed ID: 19019187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
    Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
    Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose variability and mortality in patients hospitalized with acute myocardial infarction.
    Lipska KJ; Venkitachalam L; Gosch K; Kovatchev B; Van den Berghe G; Meyfroidt G; Jones PG; Inzucchi SE; Spertus JA; DeVries JH; Kosiborod M
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):550-7. PubMed ID: 22693348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
    Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction.
    Lee GK; Lee LC; Chong E; Lee CH; Teo SG; Chia BL; Poh KK
    QJM; 2012 Nov; 105(11):1075-82. PubMed ID: 22771557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.
    Cheung NW; Wong VW; McLean M
    Diabetes Care; 2006 Apr; 29(4):765-70. PubMed ID: 16567812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-rated health predicts outcome in patients with type 2 diabetes and myocardial infarction: a DIGAMI 2 quality of life sub-study.
    Venskutonyte L; Brismar K; Öhrvik J; Rydén L; Kjellström B
    Diab Vasc Dis Res; 2013 Jul; 10(4):361-7. PubMed ID: 23673377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.
    Malmberg K
    Endocr Pract; 2004; 10 Suppl 2():13-6. PubMed ID: 15251635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes.
    Lipska KJ; Wang Y; Kosiborod M; Masoudi FA; Havranek EP; Krumholz HM; Inzucchi SE
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):236-42. PubMed ID: 20354220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.
    Staszewski J; Brodacki B; Kotowicz J; Stepien A
    J Stroke Cerebrovasc Dis; 2011; 20(2):150-4. PubMed ID: 20621520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).
    Gray CS; Hildreth AJ; Sandercock PA; O'Connell JE; Johnston DE; Cartlidge NE; Bamford JM; James OF; Alberti KG;
    Lancet Neurol; 2007 May; 6(5):397-406. PubMed ID: 17434094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.